Sargent Bickham Lagudis’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $12.3K | Hold |
435
| – | – | ﹤0.01% | 693 |
|
|
2022
Q3 | $14K | Hold |
435
| – | – | ﹤0.01% | 633 |
|
|
2022
Q2 | $14K | Hold |
435
| – | – | ﹤0.01% | 645 |
|
|
2022
Q1 | $20K | Sell |
435
-430
| -50% | -$19.8K | ﹤0.01% | 598 |
|
|
2021
Q4 | $53K | Sell |
865
-2,740
| -76% | -$168K | ﹤0.01% | 437 |
|
|
2021
Q3 | $269K | Hold |
3,605
| – | – | 0.02% | 218 |
|
|
2021
Q2 | $333K | Buy |
3,605
+1,750
| +94% | +$162K | 0.03% | 203 |
|
|
2021
Q1 | $165K | Buy |
1,855
+1,832
| +7,965% | +$163K | 0.01% | 263 |
|
|
2020
Q4 | $2K | Hold |
23
| – | – | ﹤0.01% | 800 |
|
|
2020
Q3 | $1K | Hold |
23
| – | – | ﹤0.01% | 746 |
|
|
2020
Q2 | $1K | Buy |
23
+5
| +28% | +$217 | ﹤0.01% | 736 |
|
|
2020
Q1 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 726 |
|
|
2019
Q1 | – | Sell |
-94
| Closed | -$2K | – | 802 |
|
|
2018
Q4 | $2K | Hold |
94
| – | – | ﹤0.01% | 710 |
|
|
2018
Q3 | $3K | Hold |
94
| – | – | ﹤0.01% | 712 |
|
|
2018
Q2 | $3K | Buy |
+94
| New | +$3K | ﹤0.01% | 695 |
|